Published in Nat Immunol on June 23, 2016
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science (2016) 2.18
Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 1.52
Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest (2017) 1.39
EPIDEMIOLOGY. Countering the Zika epidemic in Latin America. Science (2016) 1.24
Zika Virus: a Review from the Virus Basics to Proposed Management Strategies. Mediterr J Hematol Infect Dis (2016) 1.17
Vector Competence of American Mosquitoes for Three Strains of Zika Virus. PLoS Negl Trop Dis (2016) 1.11
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature (2016) 1.04
Zika virus - reigniting the TORCH. Nat Rev Microbiol (2016) 1.03
How Did Zika Virus Emerge in the Pacific Islands and Latin America? MBio (2016) 0.90
Zika Virus: Immunity and Vaccine Development. Cell (2016) 0.89
Zika Virus Seroprevalence, French Polynesia, 2014-2015. Emerg Infect Dis (2017) 0.89
Presence and Persistence of Zika Virus RNA in Semen, United Kingdom, 2016. Emerg Infect Dis (2017) 0.88
Dengue virus antibodies enhance Zika virus infection. Clin Transl Immunology (2016) 0.86
Vulnerability of primitive human placental trophoblast to Zika virus. Proc Natl Acad Sci U S A (2017) 0.85
Nucleic acid detection with CRISPR-Cas13a/C2c2. Science (2017) 0.85
Dynamics of Human and Viral RNA Methylation during Zika Virus Infection. Cell Host Microbe (2016) 0.84
Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. PLoS Negl Trop Dis (2016) 0.84
Development of a Zika Virus Infection Model in Cynomolgus Macaques. Front Microbiol (2016) 0.83
Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus. Open Forum Infect Dis (2016) 0.83
Modified mRNA Vaccines Protect against Zika Virus Infection. Cell (2017) 0.83
Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review. Mem Inst Oswaldo Cruz (2017) 0.81
Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barré Syndrome: Systematic Review. PLoS Med (2017) 0.81
Comparative Analysis of Dengue and Zika Outbreaks Reveals Differences by Setting and Virus. PLoS Negl Trop Dis (2016) 0.81
Structure of the immature Zika virus at 9 Å resolution. Nat Struct Mol Biol (2017) 0.80
Prospects for a Zika Virus Vaccine. Immunity (2017) 0.79
Variation in Aedes aegypti Mosquito Competence for Zika Virus Transmission. Emerg Infect Dis (2017) 0.79
Protein interactions during the flavivirus and hepacivirus life cycle. Mol Cell Proteomics (2017) 0.79
A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis. PLoS Pathog (2017) 0.79
A human antibody against Zika virus crosslinks the E protein to prevent infection. Nat Commun (2017) 0.79
Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies. Emerg Infect Dis (2017) 0.79
The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis. Microbiol Mol Biol Rev (2017) 0.78
Neutralization mechanism of a highly potent antibody against Zika virus. Nat Commun (2016) 0.78
Protective efficacy of Zika vaccine in AG129 mouse model. Sci Rep (2017) 0.78
Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Emerg Microbes Infect (2017) 0.77
Immunogenic cross-talk between dengue and Zika viruses. Nat Immunol (2016) 0.77
Zika virus genome biology and molecular pathogenesis. Emerg Microbes Infect (2017) 0.77
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight (2017) 0.76
Signaling by Antibodies: Recent Progress. Annu Rev Immunol (2017) 0.76
Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Vaccine (2017) 0.76
Emergence and Spreading Potential of Zika Virus. Front Microbiol (2016) 0.76
Three atypical lethal cases associated with acute Zika virus infection in Suriname. IDCases (2016) 0.76
Zika virus induced cellular remodelling. Cell Microbiol (2017) 0.76
Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review. Mem Inst Oswaldo Cruz (2017) 0.75
Implication of vaccination against dengue for Zika outbreak. Sci Rep (2016) 0.75
An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling. Front Immunol (2017) 0.75
Zika Virus on a Spreading Spree: what we now know that was unknown in the 1950's. Virol J (2016) 0.75
Zika Virus Serology: More Diagnostic Targets, more Reliable Answers? EBioMedicine (2017) 0.75
Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis. J Neuroimmune Pharmacol (2017) 0.75
Zika Virus Pathogenesis and Tissue Tropism. Cell Host Microbe (2017) 0.75
Fcγ-receptor IIa-mediated Src Signaling Pathway is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection. PLoS Pathog (2016) 0.75
Prolonged shedding of Chikungunya virus in semen and urine: A new perspective for diagnosis and implications for transmission. IDCases (2016) 0.75
Navigating the Zika panic. F1000Res (2016) 0.75
Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms. Proc Natl Acad Sci U S A (2016) 0.75
A Single-Cell Platform for Monitoring Viral Proteolytic Cleavage in Different Cellular Compartments. Biochem Insights (2016) 0.75
Mosquito-transmitted viruses - the great Brazilian challenge. Braz J Microbiol (2016) 0.75
Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library. F1000Res (2016) 0.75
Zika Virus Infection and Guillain-Barré Syndrome in Three Patients from Suriname. Front Neurol (2016) 0.75
Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology. Acta Med Kinki Univ (2016) 0.75
Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity. Clin Vaccine Immunol (2017) 0.75
Cost-effectiveness of dengue vaccination in Yucatán, Mexico using a dynamic dengue transmission model. PLoS One (2017) 0.75
Development of Multiplexed Infectious Disease Lateral Flow Assays: Challenges and Opportunities. Diagnostics (Basel) (2017) 0.75
Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants. PLoS One (2017) 0.75
A review of selected Arboviruses during pregnancy. Matern Health Neonatol Perinatol (2017) 0.75
Clinical Impact of Non-Congenital Zika Virus Infection in Infants and Children. Curr Infect Dis Rep (2017) 0.75
Monoclonal antibodies against Zika virus: Therapeutics and their implications for vaccine design. J Virol (2017) 0.75
Potential mechanisms of Zika-linked microcephaly. Wiley Interdiscip Rev Dev Biol (2017) 0.75
Current trends in Zika vaccine development. J Virus Erad (2017) 0.75
DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection. PLoS One (2017) 0.75
Macaque monkeys in Zika virus research: 1947-present. Curr Opin Virol (2017) 0.75
Zika virus infection confers protection against West Nile virus challenge in mice. Emerg Microbes Infect (2017) 0.75
Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Sci Rep (2017) 0.75
Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection. Nat Immunol (2017) 0.75
Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci U S A (2017) 0.75
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. PLoS Pathog (2017) 0.75
Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies. Virology (2017) 0.75
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Nat Rev Drug Discov (2017) 0.75
Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat Commun (2017) 0.75
Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys. Mol Ther (2017) 0.75
Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections. Med Microbiol Immunol (2017) 0.75
Overview on the Current Status of Zika Virus Pathogenesis and Animal Related Research. J Neuroimmune Pharmacol (2017) 0.75
Circulation of DENV2 and DENV4 in Aedes aegypti (Diptera: Culicidae) mosquitoes from Praia, Santiago Island, Cabo Verde. J Insect Sci (2017) 0.75
Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med (2009) 17.89
Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis (2008) 12.72
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet (2016) 10.08
Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96
Zika Virus Associated with Microcephaly. N Engl J Med (2016) 9.03
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med (1977) 7.01
Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis (2014) 6.75
Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet (2016) 6.55
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med (2003) 6.25
First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz (2015) 6.24
Zika Virus Outbreak, Bahia, Brazil. Emerg Infect Dis (2015) 5.64
Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis (2016) 5.40
Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med (2015) 5.16
Zika Virus Infection in Pregnant Women in Rio de Janeiro. N Engl J Med (2016) 4.82
The Brazilian Zika virus strain causes birth defects in experimental models. Nature (2016) 4.71
Antibody-enhanced dengue virus infection in primate leukocytes. Nature (1977) 4.18
Zika virus: following the path of dengue and chikungunya? Lancet (2015) 3.78
Zika virus impairs growth in human neurospheres and brain organoids. Science (2016) 3.57
Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise. Cell (2016) 3.42
Zika Virus. Clin Microbiol Rev (2016) 3.34
Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses - Brazil, 2015. MMWR Morb Mortal Wkly Rep (2016) 3.05
Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice. Cell Stem Cell (2016) 2.92
Dengue. Lancet (2014) 2.53
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol (2014) 2.34
Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil. Emerg Infect Dis (2015) 2.33
Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol (2006) 2.33
Reemergence of chikungunya virus. J Virol (2014) 2.11
Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis, Hydranencephaly and Fetal Demise. PLoS Negl Trop Dis (2016) 2.05
Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere. J Virol (2016) 2.03
The history of dengue outbreaks in the Americas. Am J Trop Med Hyg (2012) 1.87
Detection of Zika Virus Infection in Thailand, 2012-2014. Am J Trop Med Hyg (2015) 1.80
Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature (2015) 1.72
Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3. Cell Stem Cell (2016) 1.69
Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69
Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Trop (2009) 1.61
Animal models of dengue virus infection. Viruses (2012) 1.60
Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 1.52
Neutralizing antibodies after infection with dengue 1 virus. Emerg Infect Dis (2007) 1.33
East/Central/South African genotype chikungunya virus, Brazil, 2014. Emerg Infect Dis (2015) 1.29
New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol (2015) 1.10
Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep (2016) 1.08
Force of infection of dengue serotypes in a population-based study in the northeast of Brazil. Epidemiol Infect (2012) 1.08
The Epidemic of Zika Virus-Related Microcephaly in Brazil: Detection, Control, Etiology, and Future Scenarios. Am J Public Health (2016) 0.83
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol (2014) 2.34
Crucial steps in the structure determination of a coronavirus spike glycoprotein using cryo-electron microscopy. Protein Sci (2016) 0.76
Association between Guillain-Barré syndrome and Zika virus infection - Authors' reply. Lancet (2016) 0.75
High risk of dengue type 2 outbreak in French Polynesia, 2017. Euro Surveill (2017) 0.75